News


Phythera Therapeutics has been invited to give a keynote talk at the Drug Discovery Biology & Bioinformatics Strategy Meeting, West Coast USA 2024 (May 21, 2024, at the Hard Rock Hotel in San Diego, CA) with a focus on the enhanced botanical drug discovery & development for cancer therapeutics:
https://proventainternational.com/events/rd/usa-west/san-diego/drug-discovery-biology-bioinformatics-strategy-meeting-west-coast-usa-2024/


Phythera Therapeutics has been invited to give a talk at the 23rd Drug Discovery Meeting (May 2-3, 2024, at the Westin Copley Place in Boston, MA) with a focus on the enhanced botanical drug development for cancer therapeutics:
https://worldbigroup.com/23rd-Drug-Discovery/

https://www.linkedin.com/posts/wbi-drug-discovery-innovation-programme-ddip_drugdiscovery-innovation-genomics-activity-7150051961856319488-UqQY


Phythera Therapeutics is attending the 8th Tumor Models Summit in San Fransisco, CA on Jan 30-Feb 01, 2024
https://tumor-models-sf.com/


Phythera interview at the BullPen JPM in San Francisco, Jan 09, 2024, at the Golden Gate Yacht club
https://www.linkedin.com/feed/update/urn:li:activity:7151293341609918464/

 

Find out more here.


Phythera Therapeutics, Inc. participated in the partnering event (BIO JPM) Jan 08-12, 2024 in San Francisco
https://bpjw.bio.org/


Mahendra Rao, MD, PhD. (Vita Therapeutics, former PanCella, Inc., Implant Therapeutics, Inc., Plyristyx, Inc) joins Phythera Therapeutics, Inc. Advisory Board (corporate & business development)

Jim Knight, MBA (former Questcore, Inc, BioTime, Inc.) joins Phythera Therapeutics, Inc. as the Advisory Board member, corporate & business development

Natalia Dudareva, PhD. (Distinguished Professor of Biochemistry, Purdue University) agreed to join the Advisory Board of Phythera Therapeutics, Inc. (biochemistry & molecular biology of biologically active botanical compounds)

Phythera Therapeutics will be attending a Drug Developing Conference in San Francisco, CA on October 17th and 18th, 2023.

Moshe Hukaylo has joined Phythera Therapeutics, Inc., as an Advisory Board Member, Financial, Investment, & Business Consultant.

Phythera Therapeutics (the CEO, CMO, and CFO) will be attending the Drug Discovery Biology Strategy Meeting on the 8th of May 2023 in San Diego.

Mr. Ed Inal  joined Phythera Therapeutics, Inc., as an Advisory Board Member.

Ms. Nadya Issarev joined Phythera Therapeutics, Inc. as a Research Associate II. She brings her 12-year BioTime experience in microscopy and testing drugs in cancer, primary human cultured cells and stem cell cultures. We are delighted to have Nadya on our team, as she fills the much-needed role in our R&D team in San Leandro, CA. 

Phythera submitted a 1st government grant
June 2022

Phythera Therapeutics published a chapter “Stem Cell-Based Organoids for developing Vision Restoration Therapies of blindness” in the book “Recent Stem Cell Innovation in the Eye Health & Disease” (Elsevier)

Publications


We leverage the power of natural compounds and 3D stem cell biology to modulate key biological pathways in cancer and tissue regeneration and improve human health

Image

Cancer Research




Image

In Vivo Work and Genetic Animal Models




Image

Advanced Transcriptomics and Proteomics




Image

Organoids and 3D Biology Models




Image

Advanced Microscopy




Image

Stem Cells and Pluripotency




Image

Biochemical Research and Small Molecules




Image

Tissue Regeneration




Image

Artificial Intelligence